Akebia Therapeutics, Inc.
AKBA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001517022
No open-market purchases or sales by Akebia Therapeutics, Inc. insiders were filed in the last 90 days; 170 institutions reported holding it in 13F filings for Q2 2026, worth $123.2M in total; no superinvestor holds it.
Q2 2021 vs. Q1 2021
How the institutions holding Akebia Therapeutics, Inc. changed between Q1 2021 and Q2 2021.
All holders in Q2 2021All holders in Q1 2021
| Measure | Q1 2021 | Of which not filed for Q2 2021 | Q2 2021 | Change |
|---|---|---|---|---|
| Holders | 145 | 1 | 139 | −5 |
| Shares | 100.6M | 38.4K | 106.2M | +5.66M (+5.6%) |
| Value | $340.3M | $130.0K | $402.4M | +$62.2M (+18.3%) |
1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.
New holders (17)
Institutions that held Akebia Therapeutics, Inc. at the end of Q2 2021 but not at the end of Q1 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Marshall Wace, LLP | 4,109,589 | $15.6M | 0.08% |
| Woodline Partners LP | 123,774 | $469.0K | 0.01% |
| QS Investors, LLC | 122,000 | $463.0K | 0.01% |
| Birchview Capital, LP | 100,000 | $379.0K | 0.23% |
| Panagora Asset Management Inc | 70,586 | $268.0K | 0.00% |
| Qube Research & Technologies Ltd | 41,564 | $158.0K | 0.00% |
| XTX Topco Ltd | 20,589 | $78.0K | 0.03% |
| Gotham Asset Management, LLC | 19,195 | $73.0K | 0.00% |
| Bridgefront Capital, LLC | 17,189 | $65.0K | 0.02% |
| Pinz Capital Management, LP | 6,300 | $24.0K | 0.01% |
| Rockefeller Capital Management L.P. | 1,871 | $7.00K | 0.00% |
| Quadrant Capital Group LLC | 947 | $4.00K | 0.00% |
| Magnus Financial Group LLC | 1,000 | $4.00K | 0.00% |
| Dark Forest Capital Management LP | 383 | $1.00K | 0.00% |
| Toronto Dominion Bank | 22 | $0 | 0.00% |
| Focused Wealth Management, Inc | 65 | $0 | 0.00% |
| IFP Advisors, Inc | 102 | $0 | 0.00% |
Sold out (22)
Institutions that held Akebia Therapeutics, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| Two Sigma Investments, LP | 626,577 | $2.12M |
| California Public Employees Retirement System | 291,300 | $986.0K |
| Squarepoint Ops LLC | 238,876 | $809.0K |
| Maverick Capital LtdSuperinvestorMaverick Capital | 140,352 | $475.0K |
| Dynamic Technology Lab Private Ltd | 96,016 | $325.0K |
| GM Advisory Group, Inc. | 80,000 | $271.0K |
| DuPont Capital Management Corp | 72,469 | $245.0K |
| Simplex Trading, LLC | 48,118 | $162.0K |
| Sunbelt Securities, Inc. | 39,610 | $134.0K |
| Wolverine Trading, LLC | 27,071 | $84.0K |
| Man Group plc | 23,759 | $80.0K |
| Pacer Advisors, Inc. | 21,604 | $73.0K |
| Lincoln Capital Corp | 16,172 | $55.0K |
| Creative Planning | 14,653 | $50.0K |
| Two Sigma Securities, LLC | 14,046 | $48.0K |
| QCM Cayman, Ltd. | 12,059 | $41.0K |
| Leonteq Securities AG | 5,000 | $16.9K |
| Bank of Montreal | 3,878 | $12.0K |
| FMR LLC | 280 | $1.00K |
| Meeder Asset Management Inc | 270 | $1.00K |
| Disciplined Investments, LLC | 187 | $1.00K |
| Meridian Wealth Partners, LLC | 127 | $0 |
Not filed for Q2 2021 yet (1)
Institutions that held Akebia Therapeutics, Inc. at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2021 | Value, Q1 2021 |
|---|---|---|
| E Fund Management Co., Ltd. | 38,410 | $130.0K |